COVID-19 vaccination status quo

A Statista DossierPlus on the COVID19 vaccines and the ongoing vaccination campaigns as of 02/22/2021

COVID-19 vaccination status quo Since the beginning of the pandemic, the curtailment of SARS-CoV-2 has been attainable only through mobility-reducing measures (lockdowns), social distancing, and increased hygiene standards (e.g., wide usage of face masks). Vaccines are now offering hope to deescalate the pandemic without these strict measures.  As early as summer 2020, some potential vaccines cleared the rigid testing and licensure processes of national and international health authorities, a step which offered the concrete possibility of reaching a generalized immunity against COVID-19 and bringing the pandemic to an end.
As of February 2021, the mass vaccination campaigns have started in most parts of the world targeting to attain herd immunity against COVID-19 perhaps within 2021.
Statista is tracking the number of COVID-19 vaccines issued per day and comparing these figures with the average numbers needed for reaching herd immunity by the 31st of December 2021. With focus on the United States, United Kingdom, Germany, France, and Italy, the daily COVID-19 vaccines administrations in the first two countries are in sufficient quantities to reach herd immunity within 2021 year-end. By contrast, the EU countries should more than double the current number of daily vaccines' administration to reach the target.

Updated weekly. Last update: Feb. 22, 2021

For further insights on the pandemic:


Find out the whole Statista reports' library on our Report shop!
DescriptionContent

The declared target of the ongoing mass vaccination campaigns is to reach herd immunity – a sufficient share of the population being immune against the virus – to stop the spread of SARS-CoV-2. In general, the higher the contagiousness of a disease, the larger the share of the population that needs to be vaccinated to attain herd immunity. For SARS-CoV-2, the threshold is estimated at 70 to 80 percent of the population. The production, delivery, and administration of enough COVID-19 vaccine doses in order to reach this target has initiated. The question remains: How fast can herd immunity be reached?

For a deeper insight, download our COVID-19 vaccination status quo DossierPlus .

More than 7,500
companies
trust
Statista
Recommended studies and dossiers
Show more
Recent studies and dossiers
You may also be interested in...
Statista is a great source of knowledge, and pretty helpful to manage the daily work.

Christof Baron about Statista CEO, MindShare Germany

Any more questions?

Get in touch with us quickly and easily.
We are happy to help!